Guilherme Attizzani
Cardiovascular Disease · Cleveland, OHNPI 1144621889
Payments from drug & device makers
Across 1,889 payments — averaging $1493.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2.1M
- Boston Scientific$562K
- Abbott$112K
- Gentuity, LLC$16K
- Ancora Heart, Inc.$3K
- Edwards Lifesciences$743
- plus $825 from 14 others
Across 35 payments — averaging $1353.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$47K
What the payments were for
- Consulting fees$79,6566%
- Speaking & faculty fees$946,67574%
- Travel & lodging$215,34917%
- Food & beverage$38,3503%
- Other$2820%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 1,644 | $2,126,491 |
| Boston Scientific | 78 | $562,164 |
| Abbott | 109 | $111,970 |
| Gentuity, LLC | 3 | $16,000 |
| Ancora Heart, Inc. | 10 | $3,017 |
| Edwards Lifesciences | 8 | $743 |
| Novartis | 17 | $331 |
| Siemens Medical Solutions USA, Inc. | 1 | $94 |
| Gilead | 3 | $66 |
| Teleflex LLC | 3 | $63 |
| Abiomed | 2 | $63 |
| Cordis US CORP. | 1 | $31 |
| Pfizer | 2 | $28 |
| Cardiovascular Systems Inc. | 2 | $27 |
| Alnylam Pharmaceuticals Inc. | 1 | $26 |
| Terumo Medical Corporation | 1 | $22 |
| Getinge USA Sales, LLC | 1 | $21 |
| Cardiva Medical, Inc. | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Opsens Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$672,211
- CoreValve Evolut$480,555
- RESOLUTE ONYX$7,065
- Resolute$6,750
- ONYX FRONTIER$1,700
- TRICLIP$1,174
- MitraClip$895
- PORTICO$430
- MitraClip System$428
- SYNERGY$313
- SAPIEN 3 Ultra RESILIA$279
- EVOQUE$202
- PASCAL$172
- Avalus$146
- Octopus$145
- GENERAL - THERAPIES$138
- PRO-FLO XT$125
- HeartMate 3 Left Ventricular Assist Device$124
- Diamondback Coronary$123
- GENERAL - STRUCTURAL HEART$121
How this compares
$2,821,210 in reported general payments places this provider in the 95th percentile of 827 cardiovascular disease providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Cleveland
- Samir KapadiaCleveland$11.1M
- Steven NissenCleveland$5.3M
- Milind DesaiCleveland$5M
- Abraham LincoffCleveland$3.6M
- Carlos HubbardCleveland$3.1M
- Wai Hong TangCleveland$2.2M
- Mazen HannaCleveland$1.6M
- Daniel CantillonCleveland$1.3M
- Oussama WazniCleveland$665K
- Wael JaberCleveland$605K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.